Sarah Cannon Cancer Center

Summary

Sarah Cannon Cancer Center is a medical facility located in Nashville, Tennessee. This center is recognized for care of Solid Tumors, Lung Cancer, Cancer, Pancreatic Cancer, Breast Cancer and other specialties. Sarah Cannon Cancer Center is involved with conducting 219 clinical trials across 188 conditions. There are 15 research doctors associated with this hospital, such as Melissa Johnson, MD, Erika P Hamilton, Gerald Falchook, MD, and Meredith A McKean.

Top PIs

Clinical Trials running at Sarah Cannon Cancer Center

Breast Cancer

Pancreatic Cancer

Solid Tumors

Lung Cancer

Colorectal Cancer

Prostate Cancer

Endometrial Cancer

Cancer

Head and Neck Cancers

Kidney Cancer

MDX2001

for Advanced Solid Tumors

This study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.

Recruiting

1 award

Phase 1 & 2

3 criteria

PARG Inhibitor

for Advanced Cancers

This trial is testing a new drug called IDE161 to see if it is safe and effective for patients with advanced cancers that have specific genetic changes. The drug works by preventing cancer cells from repairing their DNA, which can lead to their death.

Recruiting

1 award

Phase 1

4 criteria

T-DM1 vs TH

for Breast Cancer

This research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds using one of two different combination of HER2-directed therapies as a treatment after surgery. The name of the study drugs involved are: * Trastuzumab-emtansine (T-DM1, Kadcyla) * Trastuzumab SC (Herceptin Hylecta) * Paclitaxel

Recruiting

1 award

Phase 2